These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia. Barber KE; Rybak MJ; Sakoulas G J Antimicrob Chemother; 2015 Jan; 70(1):311-3. PubMed ID: 25125677 [No Abstract] [Full Text] [Related]
8. Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease. Kuo CC; Wu VC; Huang YT; Liao CH; Hsueh PR Int J Antimicrob Agents; 2009 Jan; 33(1):96-8. PubMed ID: 18790610 [No Abstract] [Full Text] [Related]
9. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia. Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462 [TBL] [Abstract][Full Text] [Related]
10. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study. Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin. Ahmad NM; Rojtman AD Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160 [TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin. Mohan SS; McDermott BP; Cunha BA Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736 [TBL] [Abstract][Full Text] [Related]
13. [Daptomycin therapy in patients with bacteremia]. Llinares P; Iribarren JA Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():17-25. PubMed ID: 22541971 [TBL] [Abstract][Full Text] [Related]
14. Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients. Tendas A; Niscola P; Cupelli L; Spagnoli A; Scaramucci L; Giovannini M; Ales M; Cudillo L; Picardi A; Mirabile M; Bove F; Falco S; Dentamaro T; Fabritiis Pd Infect Control Hosp Epidemiol; 2011 Apr; 32(4):408-10. PubMed ID: 21460500 [No Abstract] [Full Text] [Related]
15. [Treatment of mitral MRSA endocarditis using daptomycin]. Senneville E; Beltrand E; Legout L; Leroy O; Fayad G Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204 [No Abstract] [Full Text] [Related]
16. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. Fowler VG; Boucher HW; Corey GR; Abrutyn E; Karchmer AW; Rupp ME; Levine DP; Chambers HF; Tally FP; Vigliani GA; Cabell CH; Link AS; DeMeyer I; Filler SG; Zervos M; Cook P; Parsonnet J; Bernstein JM; Price CS; Forrest GN; Fätkenheuer G; Gareca M; Rehm SJ; Brodt HR; Tice A; Cosgrove SE; N Engl J Med; 2006 Aug; 355(7):653-65. PubMed ID: 16914701 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients. Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506 [TBL] [Abstract][Full Text] [Related]
18. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920 [TBL] [Abstract][Full Text] [Related]